Vulnerabilities

Vulnerability · CVE-2025-8276

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in

Published Sep 16, 2025 · catalog updated Jun 5, 2026 · Patika Global Technologies HumanSuite

Last checked Oct 29, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-8276. EPSS is 0.34%. Act only if a listed version of Patika Global Technologies HumanSuite is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Critical9.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.34%
Remediation
Version ranges on file
Affected products
vendor Patika Global Technologies HumanSuite 0 <53.21.0

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in Patika Global Technologies HumanSuite allows Cross-Site Scripting (XSS), Phishing. This issue affects HumanSuite: before 53.21.0.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Patika Global Technologies HumanSuite 0 <53.21.00 <53.21.0

How to fix CVE-2025-8276

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-8276. EPSS is 0.34%. Act only if a listed version of Patika Global Technologies HumanSuite is installed.

Which versions are affected?

Compare what you have installed with Patika Global Technologies HumanSuite 0 <53.21.0 0 <53.21.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.34%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Sep 16, 2025 · EUVD

    Detected

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in Patika Global Technologies HumanSuite allows Cross-Site Scripting (XSS), Phishing. This issue affects HumanSuite: before 53.21.0.

  2. Jun 5, 2026 · EUVD

    Updated

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in Patika Global Technologies HumanSuite allows Cross-Site Scripting (XSS), Phishing. This issue affects HumanSuite: before 53.21.0.

Sources

  • CVE.orgVulnerability recordCVE-2025-8276

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-8276

    30-day exploitation probability 0.34%

    first.org
  • EUVDVulnerability recordEUVD-2025-29619

    Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in Patika Global Technologies Hum

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSOct 23, 2026
  • CVE.orgOct 22, 2026
  • EUVDOct 22, 2026